David Topper

David Topper

Former Chief Financial OfficeratArcutis Biotherapeutics· In proxies 2024–2025

Pay in FY2025-63% from the year before · Arcutis Biotherapeutics stock +108.5% the same year

David Topper was paid $1.9M in FY2025 (Dec), down 63%. Arcutis Biotherapeutics stock rose 108.5% that year.

Pay$100 in the stock at the end of FY23 → $899
Pay is from the Summary Compensation Table of each Arcutis Biotherapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Arcutis BiotherapeuticsPublic company · 2 yr
    • Former Chief Financial Officer2024 – Present · 2 yrStock in role +915%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?